Preferences and willingness for starting daily, on-demand, and long-acting injectable HIV pre-exposure prophylaxis among transfeminine persons in the US, 2022–2023
Duygu İşlek(Emory University), Vani Vannappagari(ViiV Healthcare (Spain)), Stefan Baral(Johns Hopkins University), Jennifer L. Glick(Louisiana State University Health Sciences Center New Orleans), Mariah Valentine-Graves(Emory University), Patrick S. Sullivan(Emory University), Annemiek de Ruiter(ViiV Healthcare (Spain)), Danielle Friedman Nestadt(Johns Hopkins University), Savannah Winter(Emory University), Carolyn Brown(Dumfries and Galloway Royal Infirmary), Jeb Jones(Emory University), Travis Sanchez(Emory University), Supriya Sarkar, Joanna A. Caldwell(Emory University)
Cited by 3
Related Papers
Assessing differential impacts of COVID-19 on black communities
|Annals of Epidemiology|2020|1.2k
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|631
Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011
|AIDS|2014|397
Risk for COVID-19 infection and death among Latinos in the United States: examining heterogeneity in transmission dynamics
|Annals of Epidemiology|2020|361